In Which Patients is Cytomegalovirus Most Harmful?
JUN 11, 2017 | CONTAGION® EDITORIAL STAFF
Genovefa Papanicolaou, MD, Attending Physician, Infectious Diseases, Memorial Sloan Kettering Cancer Center, explains in which patient population is CMV most harmful.
Interview Transcript (slightly modified for readability)
“[Cytomegalovirus] can be particularly harmful in patients that have undergone bone marrow transplants.
Actually, CMV is the single most important viral infection [to watch for] after transplantation. Approximately 40% up to 70% of patients that are seropositive for CMV might [experience] CMV reactivation after transplant.” DISCLOSURES: Genofeva Papanicolaou has received research funding from Merck and consultant and research funding from Astellas and Chimerix.
To stay informed on the latest in infectious disease news and developments, please sign upfor our weekly newsletter.
Contagion® is a fully integrated news resource covering all areas of infectious disease. Through our website, quarterly journal, email newsletters, social media outlets, and Outbreak Monitor we provide practitioners and specialists with disease-specific information designed to improve patient outcomes and assist with the identification, diagnosis, treatment, and prevention of infectious diseases. Our mission is to assure that the healthcare community and public have the knowledge to make more informed choices and have a positive impact on patient outcomes.
2 Clarke Drive
Cranbury, NJ 08512